During the past decade, Istituto Clinico Humanitas conducted 383 clinical trials. In the 10-year time frame, 383 clinical trials started and 111 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 136 clinical trials started and 79 clinical trials were completed. i.e. 58.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istituto Clinico Humanitas" #1 sponsor was "Istituto Clinico Humanitas" with 104 trials, followed by "Celgene" with 24 trials sponsored, "Humanitas Clinical and Research Center" with 20 trials sponsored, "Eli Lilly and Company" with 18 trials sponsored and "Armando Santoro, MD" with 18 trials sponsored. Other sponsors include 380 different institutions and companies that sponsored additional 178 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Clinico Humanitas" #1 collaborator was "Istituto Clinico Humanitas" with 7 trials as a collaborator, "PharmaMar" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator and "Gilead Sciences" with 4 trials as a collaborator. Other collaborators include 235 different institutions and companies that were collaborators in the rest 203 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Clinico Humanitas" are "Ulcerative Colitis" (26 trials), "Crohn Disease" (18 trials), "Coronary Artery Disease" (16 trials), "Crohn's Disease" (16 trials) and "Breast Cancer" (15 trials). Many other conditions were trialed in "Istituto Clinico Humanitas" in a lesser frequency.

Most popular intervention types in "Istituto Clinico Humanitas" are "Drug" (334 trials), "Device" (60 trials), "Other" (57 trials), "Procedure" (54 trials) and "Radiation" (30 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (80 trials), "Gemcitabine" (19 trials), "Cisplatin" (10 trials), "Carboplatin" (8 trials) and "Cyclophosphamide" (8 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Clinico Humanitas" are 532 trials for "All" genders, 23 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 210 active trials in "Istituto Clinico Humanitas". 5 are not yet recruiting, 119 are recruiting, 85 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 231 completed trials in Istituto Clinico Humanitas, undefined suspended trials, and 53 terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Clinico Humanitas, 53 "Phase 1" clinical trials were conducted, 155 "Phase 2" clinical trials and 167 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 83 trials that are defined as “Not Applicable".

Istituto Clinico Humanitas has several departments that took part in Clinical trials: "IRCCS Istituto Clinico Humanitas; Oncologia" - 17 trials, "IBD Center" - 5 trials, "IRCCS - Istituo Clinico Humanitas - Humanitas Cancer Center" - 5 trials, "Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia" - 30 trials